pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 443
- Patents
- 706
Proleukin 18 x 106 IE Poeder voor oplossing voor injectie of infusie
Phase 2 · small molecule · MDS with excess blasts, MDS/AML or AML patients
Proleukin 18 x 106 IE Poeder voor oplossing voor injectie of infusie for MDS with excess blasts, MDS/AML or AML patients is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Internal code HEMAML42-NK4AML
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Disc Medicine
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- MDS with excess blasts, MDS/AML or AML patients
- Status
- active
- Trials
- 1